Co-founder and CEO: Ass. Prof. Dr. Volker M. Lauschke, PhD, BBA
Volker obtained his PhD from the EMBL and the Combined Faculty
of Natural Sciences and Mathematics of the University of Heidelberg, Germany for the development of a novel primary cell culture system
and his work on tissue patterning based on phase-encoding using molecular oscillators. In 2014, he moved to Karolinska Institutet as a
MarieCurie fellow to work on the development of physiological hepatic model systems. He is Assistant Professor for Liver function and regeneration
with emphasis on drug development since Jan. 2017. His research is focused on hepatic toxicity and disease models, hepatocyte differentiation
plasticity in health and disease as well as the genetic basis of drug response.
In addition, Volker obtained a BBA degree from the University of Hagen, Germany, and has successfully completed academic courses Law.